Researcher

Dr. Wanatsanan Chulrik

Documents 3 Internal projects 2 External projects 0

School
School of Allied Health Sciences

Major
Medical Technology Program

Center of excellence / Research center
Food Technology and Innovation Center of Excellence

Email
wanatsanan.chu@wu.ac.th

ORCID
00000-0003-2804-492

SCOPUS
57215857649

Never entered data

Quartile	Manuscript in Preparation			Journal Processing			Research Article
	Experiment	Data analysis	Review by mentor	Submission	Under review	Revision	Accepted Pending approval / Approved		Published Pending approval / Approved
	Experiment	Data analysis	Review by mentor	Submission	Under review	Revision	Pending	Approved	Pending	Approved
Q1	0	0	0	0	0	0	0	0	0	0
Q2	0	0	0	0	0	0	0	0	0	0
Q3	0	0	0	0	0	0	0	0	0	0
Q4	0	0	0	0	0	0	0	0	0	0
Total	0	0	0	0	0	0	0	0	0	0

	Article	Participants	Journal	Fiscal	Selected 1 : 1	Status	Approval	assessment
1	25762 \| In Silico Investigation Reveals IL-6 as a Key Target of Asiatic Acid in Osteoporosis: Insights from Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation (2026-01-15) 10.3390/medsci14010041	Chulrik, Wanatsanan (F) Duangchan, Thitinat (C) Tedasen, Aman (Co) Kooltheat, Nateelak (Co) Kimseng, Rungruedee (Co)	Medical Sciences (Q1), Volume 14, Issue 41			Published	Approved
2	25731 \| Mechanistic insights into the anti-inflammatory effects of isocoronarin D associated with reduced PKCδ and PI3K/Akt signalling in LPS-activated macrophages (2026-01-01) 10.1007/s10787-026-02115-7	Chulrik, Wanatsanan (F) Chunglok, Warangkana (C) Jansakun, Chutima (Co) Tedasen, Aman (Co) Rungruedee, Kimseng (Co) Ratchanaporn, Chokchaisiri (Co) Wilanee, Chunglok (Co) Apichart, Suksamrarn (Co)	Inflammopharmacology (Q1)			Published	Approved
3	25221 \| Association Between ABO or Rh Blood Groups and Chikungunya Virus Infection: A Systematic Review and Meta-Analysis (2025-08-01) 10.3390/medicina61081316	Rattanapan, Yanisa (F) Duangchan, Thitinat (C) Rasaratnam, Karunaithas (Co)	Medicina Lithuania (Q1), Volume 61, Issue 8, Pages number 1316		Duangchan, Thitinat เคลมผลงาน 1:1 ในปี 2025	Published	Approved

	Document title	Participation	Duration	Fiscal year	Funding	Progress
1	WU69250 \| Potential effects of aporphine alkaloid from Stephania pierrei against pulmonary fibrosis	Dr. Wanatsanan Chulrik 80 % Assoc.Prof.Dr. Warangkana Chunglok 20 %	15 Mar 2026 - 14 Mar 2027 The time has not been extended	2026	100,000	In preparation
2	WU67233 \| การศึกษาฤทธิ์ต้านการอักเสบของสารแลบแดนไดเทอร์พีนจากว่านชักมดลูก ในเซลล์ภูมิคุ้มกันที่ถูกกระตุ้นด้วยเอ็นโดท็อกซิน และการจำลองการจับเชิงโมเลกุล	Dr. Wanatsanan Chulrik 90 % Dr. Chutima Jansakun 10 %	29 Apr 2024 - 28 Apr 2025 The time has not been extended	2024	100,000	In preparation

	Document title	Participation	Duration	Source	Fiscal year	Funding	Progress